# Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

> **NCT03418779** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- IgA Nephropathy at High Risk of Developing ESRD

## Interventions

- **DRUG:** The Yi-Qi-Qing-Jie herbal compound
- **DRUG:** Immunosuppressants
- **OTHER:** Optimized Supportive Care
- **OTHER:** Yi-Qi-Qing-Jie herbal compound placebo

## Key facts

- **NCT ID:** NCT03418779
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-04
- **Primary completion:** 2024-09-25
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03418779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03418779, "Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03418779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*